Imagine detecting breast cancer with a simple blood test. We partnered with Bcal Diagnostics to turn this vision into reality, leading to the development of Australia's first commercialised, lipid-based blood test for breast cancer detection building. 

And in partnership with breast screen, we are now leading the world first clinical study to have the next generation of blood tests for breast cancer. 

We are measuring multiple types of biological signals from blood, from RNAs to proteins and beyond, and harnessing the power of artificial intelligence to build a blood test, which can detect cancer earlier, more accessible, precise, and personalised.

We often diagnose cancer when we see the actual lump in medical imaging. 

Tumours no matter how small they are in constant communication with blood and they spill over a lot of materials into circulation, and these molecules can be used as signals to detect cancer early on, months or even years before we see the lump or actual tumour.

We go and we have a blood test. And then those analytes that we have identified go into AI models that reveal the existence of the disease. 

I see the future that we go to our GP, we have our blood test and all other information in the cloud, and it would be connected to an AI system which analyses them all and comes up with a comprehensive explainable report with a decision, both in terms of diagnosis as well as treatment regime or plan, and that would be accessible to everyone everywhere with a cost which is affordable.